Blog

Jonathan Wogel, Executive Chairman of UKI2S portfolio company Zentraxa, has a career of two halves, starting his journey in large, international corporations, then transitioning into the SME and start-up arena. Born in the UK, educated in the UK & USA and having led a truly international career, he offers a unique view on leadership, work […]

read more

Against the challenging backdrop of a global pandemic, 2020 saw the successful merger of UKI2S portfolio company Perfectus Biomed and US-based Extherid Biosciences. There are of course specific challenges for a UK/US merger, but the value of cross-cultural collaboration across all levels of the business should be celebrated particularly for the personal growth and development […]

read more

2021 is set to be an interesting year for gene editing. Gene therapy research is in its adolescence, and the ups and downs are played out almost every day, with plenty of innovative breakthroughs and a few regulatory setbacks. With lots of unknowns and much to be excited about, we spoke with Jon Moore, Executive […]

read more

1 2 3 36